Skip to main content

Table 3 Pathological types in Non-diabetic kidney disease

From: Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021

Type

All (n = 244)

NDKD Group (n = 112)

MIX Group (n = 14)

IgA N, n( %)

69 (28.28)

59 (52.68)

10 (71.43)

MN, n( %)

23 (9.43)

21 (18.75)

2 (14.29)

MCD, n( %)

6 (2.46)

6 (5.36)

0

MsPGN, n( %)

5 (2.05)

5 (4.46)

0

Hypertensive nephropathy, n( %)

5 (2.05)

4 (3.57)

1 (7.14)

HSPN, n( %)

5 (2.05)

5 (4.46)

0

PsG, n( %)

3 (1.23)

3 (2.68)

0

Amyloid nephropathy, n( %)

4 (1.64)

3 (2.68)

1 (7.14)

ANCA relative glomerulonephritis, n( %)

4 (1.64)

4 (3.57)

0

FSGS, n( %)

3 (1.23)

3 (2.68)

0

LN, n( %)

3 (1.23)

3 (2.68)

0

MPGN, n( %)

1 (0.41)

1 (0.89)

0

C3G, n( %)

1 (0.41)

1 (0.89)

0

OaG, n( %)

1 (0.41)

1 (0.89)

0

  1. The data were presented as the frequency (%). NDKD Non-diabetic kidney disease; MIX Group, NDKD superimposed DKD, IgA N IgA nephropathy, MN Membranous nephropathy, MCD Minimal change disease, MsPGN Mesangial proliferative glomerulonephritis, HSPN Henoch-Schonlein purpura nephritis, PsG Proliferative-sclerosing glomerulonephritis, FSGS Focal segmental glomerulosclerosis, LN Lupus nephritis, MPGN Membranoproliferative glomerulonephritis, C3G C3 glomerulopathy, OaG Obesity-associated glomerulomegaly. Six patients were diagnosed as IgA N combined with MN, and one patients was diagnosed as MCD combined with hypertensive nephropathy